Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan M Robbins

Showing results (21-30 of 77) with videos related to

Pageof 8
Sort By:
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 16, 2011
Unrecognized glucose intolerance is common in pulmonary arterial hypertensionMeredith E Pugh, Ivan M Robbins, Todd W Rice, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2002
Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenolKarl P Kuhn, Daniel W Byrne, Patrick G Arbogast, et al.
Chest|May 31, 2011
End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatmentAnna R Hemnes, Meredith E Pugh, Alexander L Newman, et al.
Journal of the American College of Cardiology|June 15, 2004
Pathologic assessment of vasculopathies in pulmonary hypertensionGiuseppe G Pietra, Frederique Capron, Susan Stewart, et al.
Pulmonary Circulation|September 10, 2013
Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertensionKen Monahan, Theresa A Scott, Yan Ru Su, et al.
Plos One|October 15, 2013
Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertensionEvan L Brittain, Meredith E Pugh, Li Wang, et al.
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Annals of the American Thoracic Society|March 28, 2017
End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial HypertensionCaitlin E Welch, Evan L Brittain, Alexander L Newman, et al.
Pulmonary Circulation|June 3, 2016
Severity of pulmonary hypertension and obesity are not associated with worse functional outcomes after pulmonary thromboendarterectomyDaniel T Matthews, Catherine N Le, Ivan M Robbins, et al.
Pulmonary Circulation|July 10, 2014
Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertensionLevi Benson, Evan L Brittain, Meredith E Pugh, et al.
Pageof 8

Showing results (21-30 of 77) with videos related to

Sort By:
Pageof 8
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|April 16, 2011
Unrecognized glucose intolerance is common in pulmonary arterial hypertensionMeredith E Pugh, Ivan M Robbins, Todd W Rice, et al.
American Journal of Respiratory and Critical Care Medicine|November 26, 2002
Outcome in 91 consecutive patients with pulmonary arterial hypertension receiving epoprostenolKarl P Kuhn, Daniel W Byrne, Patrick G Arbogast, et al.
Chest|May 31, 2011
End tidal CO(2) tension: pulmonary arterial hypertension vs pulmonary venous hypertension and response to treatmentAnna R Hemnes, Meredith E Pugh, Alexander L Newman, et al.
Journal of the American College of Cardiology|June 15, 2004
Pathologic assessment of vasculopathies in pulmonary hypertensionGiuseppe G Pietra, Frederique Capron, Susan Stewart, et al.
Pulmonary Circulation|September 10, 2013
Reproducibility of intracardiac and transpulmonary biomarkers in the evaluation of pulmonary hypertensionKen Monahan, Theresa A Scott, Yan Ru Su, et al.
Plos One|October 15, 2013
Predictors of diastolic-to-wedge gradient in patients evaluated for pulmonary hypertensionEvan L Brittain, Meredith E Pugh, Li Wang, et al.
Chest|July 11, 2003
Effects of the dual endothelin receptor antagonist bosentan in patients with pulmonary arterial hypertension: a 1-year follow-up studyOlivier Sitbon, David B Badesch, Richard N Channick, et al.
Annals of the American Thoracic Society|March 28, 2017
End-Tidal Carbon Dioxide as a Prognostic Feature in Pulmonary Arterial HypertensionCaitlin E Welch, Evan L Brittain, Alexander L Newman, et al.
Pulmonary Circulation|June 3, 2016
Severity of pulmonary hypertension and obesity are not associated with worse functional outcomes after pulmonary thromboendarterectomyDaniel T Matthews, Catherine N Le, Ivan M Robbins, et al.
Pulmonary Circulation|July 10, 2014
Impact of diabetes on survival and right ventricular compensation in pulmonary arterial hypertensionLevi Benson, Evan L Brittain, Meredith E Pugh, et al.
Pageof 8